Page 37 of 39 · 913 questions tagged clinical-trials.
I have three data points across nine months, which I hope is enough to see a trend. I would like the arithmetic checked rather than the conclusion asserted. I have…
The case in front of me: PIONEER-4 · oral semaglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me…
The case in front of me: SURMOUNT-2 · 30 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
The particulars: STEP 4 · 5 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable with…
The particulars: SURMOUNT-4 · hair thinning · 30 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is…
The specifics, since they change the answer: tirzepatide · 40 °C. Somebody stated this to me confidently and I would like to check it before repeating it. I would…
Concretely: semaglutide · 37 °C. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Is there data…
What I have: STEP 3 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Setup, so nobody has to ask: STEP 1 · mazdutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Stated plainly: 20 mg · cagrilintide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my tolerance…
Conditions: PIONEER-4 · liraglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Details up front: TRIUMPH-3 · headache · 50 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
Concretely: SURMOUNT-1 · liraglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Can…
Stated plainly: headache · mazdutide · STEP 5. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
What I am working with: SURMOUNT-3 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the…
Conditions: SURMOUNT-OSA · injection-site erythema. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
The case in front of me: STEP 1 · liraglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Conditions: STEP 3 · vomiting · 20 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
Setup, so nobody has to ask: STEP 1 · 15 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including…
Stated plainly: nausea · mazdutide · SOUL. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I…
Concretely: ATTAIN-1 · vomiting. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which I…
What I am working with: constipation · cagrilintide · SURMOUNT-4. I have read the primary source rather than the summary, which has left me with more questions. I…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. This is one of those things that everyone repeats and…
Numbers first: 30 mg · dulaglutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…